Home › Hypopharyngeal Cancer › Washington
Hypopharyngeal Cancer clinical trials in Washington, DC
3 studies for Hypopharyngeal Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
RecruitingPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- George Washington University Medical Center, Washington D.C.
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- George Washington University Medical Center, Washington D.C.
Hypopharyngeal Cancer trials in other cities
- Chicago, IL6 studies
- Atlanta, GA5 studies
- Richmond, VA5 studies
- Milwaukee, WI5 studies
- Baltimore, MD4 studies
- Kansas City, MO4 studies
- Edison, NJ4 studies
- Portland, OR4 studies
- Queens, NY4 studies
- New York City, NY4 studies
- Aurora, IL4 studies
- Flint, MI4 studies
Other studies in Washington
- Cancer (all types)60 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer44 studies
- Metastatic Cancer44 studies
- Lung Cancer41 studies
- Prostate Cancer39 studies
- Obesity34 studies
- Colorectal Cancer28 studies
- Cardiovascular Disease27 studies
- Bladder Cancer26 studies
- Ovarian Cancer25 studies
- Lymphoma23 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.